Lipopolysaccharide promotes adhesion and invasion of hepatoma cell lines HepG2 and HepG2.2.15

Inflammation and infection have been linked to the bionomics of many cancers, including hepatocellular carcinoma (HCC). Some bacteria, such as Helicobacter pylori, have been found in pathological specimens from patients with HCC. However, little is known about the direct effects of bacteria or their components on hepatoma cells. We analyzed the in vitro proliferation, adhesion and invasion responses of the tumor cell lines HepG2 and HepG2.2.15 to lipopolysaccharide (LPS), a cell wall constituent of Gram-negative bacteria. HepG2 and HepG2.2.15 cells show increased proliferation in response to LPS. Their invasion and adhesion abilities were also increased in response to LPS, which may be related to increased gene expression of interleukin-8 and transforming growth factor-β1. We infer that bacteria may be ignored by immune systems and directly promote adhesion and invasion of hepatoma cells through LPS.

[1]  H. Redmond,et al.  Endotoxin/Lipopolysaccharide Activates NF-κB and Enhances Tumor Cell Adhesion and Invasion Through a β1 Integrin-Dependent Mechanism , 2003, The Journal of Immunology.

[2]  H. Redmond,et al.  The role of endotoxin/lipopolysaccharide in surgically induced tumour growth in a murine model of metastatic disease , 1999, British Journal of Cancer.

[3]  J. Pollard.  Tumour-educated macrophages promote tumour progression and metastasis , 2004, Nature Reviews Cancer.

[4]  F. Fallarino,et al.  Spontaneous Rejection of Poorly Immunogenic P1.HTR Tumors by Stat6-Deficient Mice1 , 2000, The Journal of Immunology.

[5]  C. Bucana,et al.  Nuclear Factor-κB Activity Correlates with Growth, Angiogenesis, and Metastasis of Human Melanoma Cells in Nude Mice , 2000 .

[6]  Andreas Sommer,et al.  NF-κB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression , 2004 .

[7]  P. Tobias,et al.  TLR4 Is the Signaling but Not the Lipopolysaccharide Uptake Receptor12 , 2004, The Journal of Immunology.

[8]  E. Uhl,et al.  Bacterial Endotoxin (lipopolysaccharide) Stimulates Interleukin‐6 Production and Inhibits Growth of Pituitary Tumour Cells Expressing the Toll‐Like Receptor 4 , 2005, Journal of neuroendocrinology.

[9]  R. Chen,et al.  TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer. , 2006, Cancer research.

[10]  Jia-Jun Liu,et al.  The significance of Toll-like receptor 4 (TLR4) expression in patients with chronic hepatitis B. , 2008, Clinical and investigative medicine. Medecine clinique et experimentale.

[11]  W. Kamps,et al.  Endothelial Cells Are Main Producers of Interleukin 8 through Toll-Like Receptor 2 and 4 Signaling during Bacterial Infection in Leukopenic Cancer Patients , 2003, Clinical Diagnostic Laboratory Immunology.

[12]  A. Nanbo,et al.  Lipopolysaccharide stimulates HepG2 human hepatoma cells in the presence of lipopolysaccharide-binding protein via CD14. , 1999, European journal of biochemistry.

[13]  C. Bucana,et al.  Lipopolysaccharide‐induced metastatic growth is associated with increased angiogenesis, vascular permeability and tumor cell invasion , 2002, International journal of cancer.

[14]  Nan Li,et al.  TLR4 signaling promotes immune escape of human lung cancer cells by inducing immunosuppressive cytokines and apoptosis resistance. , 2007, Molecular immunology.

[15]  J. Wang,et al.  Tumor cell adhesion to endothelial cells is increased by endotoxin via an upregulation of beta-1 integrin expression. , 2001, The Journal of surgical research.

[16]  T. Lawrence,et al.  Inflammation and cancer: a double-edged sword. , 2007, Cancer cell.

[17]  B. Choi,et al.  The aqueous extract from Artemisia capillaris Thunb. inhibits lipopolysaccharide-induced inflammatory response through preventing NF-kappaB activation in human hepatoma cell line and rat liver. , 2004, International journal of molecular medicine.

[18]  S. Chiang,et al.  Acetaldehyde induces matrix metalloproteinase-9 gene expression via nuclear factor-kappaB and activator protein 1 signaling pathways in human hepatocellular carcinoma cells: Association with the invasive potential. , 2007, Toxicology letters.

[19]  S. Fan,et al.  Evaluation of Nuclear Factor-κB, Urokinase-Type Plasminogen Activator, and HBx and Their Clinicopathological Significance in Hepatocellular Carcinoma , 2004, Clinical Cancer Research.

[20]  H. Redmond,et al.  Integrin-Dependent Mechanism , 2002 .

[21]  S. Akira,et al.  Toll-like receptor function and signaling. , 2006, The Journal of allergy and clinical immunology.

[22]  Hirotoshi Nakamura,et al.  Involvement of platelet-activating factor in hepatic apoptosis and necrosis in chronic ethanol-fed rats given endotoxin. , 2002, Liver.

[23]  H. Pehamberger,et al.  NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression. , 2004, The Journal of clinical investigation.

[24]  G. Rosen,et al.  Triptolide sensitizes lung cancer cells to TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by inhibition of NF-κB activation , 2002, Experimental & Molecular Medicine.

[25]  Dimitris Kletsas,et al.  The Proinflammatory Phenotype of Senescent Cells: The p53‐Mediated ICAM‐1 Expression , 2004, Annals of the New York Academy of Sciences.

[26]  C. Bucana,et al.  Nuclear factor-kappaB activity correlates with growth, angiogenesis, and metastasis of human melanoma cells in nude mice. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[27]  C. Rossetti,et al.  Melanoma cell lines are responsive in vitro to lipopolysaccharide and express TLR-4. , 2006, Cancer letters.

[28]  F. Brunello,et al.  Helicobacter pylori seroprevalence in patients with cirrhosis of the liver and hepatocellular carcinoma. , 2003, Cancer detection and prevention.

[29]  R. Baron,et al.  Extrahepatic metastases of hepatocellular carcinoma. , 2000, Radiology.

[30]  Ø. Bruserud,et al.  Osteoblasts increase proliferation and release of pro-angiogenic interleukin 8 by native human acute myelogenous leukemia blasts. , 2004, Haematologica.

[31]  X. Tian,et al.  Identification of helicobacter species in human liver samples from patients with primary hepatocellular carcinoma , 2004, Journal of Clinical Pathology.

[32]  A. Hoffmann,et al.  Signaling pathways and genes that inhibit pathogen-induced macrophage apoptosis--CREB and NF-kappaB as key regulators. , 2005, Immunity.

[33]  I. M. Neiman,et al.  [Inflammation and cancer]. , 1974, Patologicheskaia fiziologiia i eksperimental'naia terapiia.

[34]  A. Torii,et al.  Potential role of Helicobacter pylori in hepatocarcinogenesis. , 2004, International Journal of Molecular Medicine.

[35]  A. Iwasaki,et al.  Toll-like receptor control of the adaptive immune responses , 2004, Nature Immunology.